Search

everythinglearnresearchcommunity

for

Search:↓

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

A man's rare tumor caused unusual nerve-related symptoms that improved after surgery.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Candida antigen is an effective and promising treatment for alopecia areata.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

IL-1 alpha stops hair follicle growth and hair production.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Certain gene variations are linked to alopecia areata.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.